Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
Abingworth, afflicted, Alison, amplified, anesthesiologist, anonymized, Aspire, ATM, augment, belief, Biden, bona, Bruton, Cantor, caution, Commonwealth, constitutionality, COVID, DCFI, Deadline, deepened, DFCI, economy, FedEx, fide, Fitzgerald, Governor, herd, home, hope, inconsistent, intelligence, Lawton, lift, magnitude, metric, metropolitan, occued, OfferingSM, overarching, overdue, pace, pandemic, postal, prioritization, prioritizing, quarantine, recession, refund, remote, remotely, residence, resold, Riley, RPD, slowdown, survey, syndicate, titration, undiagnosed, unnecessary, verification, vii, virtual, visit, widespread, withholding, worsen, worsening
Removed:
anniversary, annum, assumption, billion, biosimilar, bore, bulk, cap, clarifying, classifying, clause, coli, commerce, concurrent, consummation, CRO, curtail, deep, dependence, devoted, dual, earned, element, elimination, enactment, escalation, Escherichia, exhaust, financed, fiscal, fixed, freely, hiring, incorporate, Klebsiella, led, lessee, lowest, mAb, mandatorily, marginal, mbH, noncontrolling, nonpublic, novelty, organizing, passing, prevalent, promising, proper, ranging, redeem, reimburse, rejection, released, replaced, requesting, respiratory, retirement, retrospectively, revocation, round, schema, securing, shortening, software, statistical, statistically, step, sterreichische, syncytial, tenant, thereon, tranche, unamortized, unaudited, unpaid, unrealized, vested, viability, Vice, wrong
Filing tables
Filing exhibits
Related press release
Associated XFOR transcripts
XFOR similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-229377, 333-233161, 333-242372 and 333-249544) and Form S-8 (Nos. 333-221622, 333-223539, 333-230181, 333-230499, 333-233162, 333-237164 and 333-239082) of X4 Pharmaceuticals, Inc. of our report dated March 19, 2021 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 19, 2021